IPOGrid
0001853921
IPO filing research

Scribe Therapeutics, Inc.

Biological Products, (No Diagnostic Substances)

ipo amended S-1

Scribe Therapeutics, Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: S-1 on 2026-07-02.

Filing Timeline

SEC EDGAR
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS/A in the pre-IPO sequence.
2026-07-02 · 0001193125-26-294804
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
2026-06-12 · 0001193125-26-269670
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
2026-03-06 · 0001193125-26-096844
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
2026-01-09 · 0001193125-26-009106

Recent News

No recent news stored for this issuer.